Estimating the probability of toxicity at the target dose following an up‐and‐down design
暂无分享,去创建一个
[1] G. Barrie Wetherill,et al. Sequential methods in statistics , 1967 .
[2] B E Storer,et al. Small-sample confidence sets for the MTD in a phase I clinical trial. , 1993, Biometrics.
[3] J O'Quigley,et al. Continual reassessment method: a likelihood approach. , 1996, Biometrics.
[4] F. T. Wright,et al. Order restricted statistical inference , 1988 .
[5] Nancy Flournoy,et al. Dose Finding Using the Biased Coin Up‐and‐Down Design and Isotonic Regression , 2002, Biometrics.
[6] S. Goodman,et al. Some practical improvements in the continual reassessment method for phase I studies. , 1995, Statistics in medicine.
[7] S. Durham,et al. A random walk rule for phase I clinical trials. , 1997, Biometrics.
[8] L V Rubinstein,et al. A comparison of two phase I trial designs. , 1994, Statistics in medicine.
[9] J. Pedoe,et al. Sequential Methods in Statistics , 1966 .
[10] J O'Quigley,et al. Estimating the probability of toxicity at the recommended dose following a phase I clinical trial in cancer. , 1992, Biometrics.
[11] J O'Quigley,et al. Continual reassessment method: a practical design for phase 1 clinical trials in cancer. , 1990, Biometrics.